|
Market Closed -
NYSE
21:10:00 24/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 39.53 USD | -0.30% |
|
-0.28% | +22.31% |
| Current month | +7.99% | ||
| 1 month | +4.87% |
Investment objective
The iShares Neuroscience and Healthcare ETF (the Fund) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 205.40USD | -1.14% | +12.46% | 4.89% | |
| 368.03USD | -2.10% | +24.87% | 4.75% | |
| 60.56USD | -0.35% | +35.12% | 3.98% | |
| 71.06USD | +1.78% | -6.45% | 3.93% | |
| 58.20USD | +3.01% | +32.12% | 3.91% | |
| 29.65USD | +0.51% | +11.01% | 3.89% | |
| 218.12USD | +0.62% | +23.94% | 3.88% | |
| 48.87USD | +1.12% | +74.66% | 3.79% | |
| 153.04USD | +0.31% | +7.90% | 3.65% | |
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/08/26 | US$39.53 | -0.30% | 983 |
| 21/08/26 | US$39.65 | +0.68% | 538 |
| 20/08/26 | US$39.38 | -3.16% | 692 |
| 19/08/26 | US$40.67 | +2.26% | 4,321 |
| 18/08/26 | US$39.77 | +0.32% | 1,411 |
Other stock markets
Delayed Quote NYSE
Last update August 24, 2026 at 09:10 pm
Description
| US46436E3532 | |
|---|---|
| Total Expense Ratio | 0.0047 |
| Asset Class | Stocks |
| Currency | |
| Provider | |
| Underlying | NYSE FactSet Global Neuro Biopharma and MedTech Net Index - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Date of creation |
23/08/2022
|
AuM evolution - 11/08/2026
| AuM (USD) | 9.14M |
|---|---|
| AuM 1M | 9.14M |
| AuM 3 months | 9.14M |
| AuM 6 months | 9.14M |
| AuM 12 months | 9.14M |
- Stock Market
- ETF
- IBRN ETF
Select your edition
All financial news and data tailored to specific country editions
